SMTL ID : 4otg.1

Crystal Structure of PRK1 Catalytic Domain in Complex with Lestaurtinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x 2V9: Lestaurtinib(Non-covalent)

2V9.1: 14 residues within 4Å: Chain A: L.20, G.21, R.22, F.25, V.28, A.41, E.95, Y.96, S.97, G.100, D.101, L.146, A.156, D.157 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.20, A:L.20, A:F.25, A:F.25, A:V.28, A:Y.96, A:D.101, A:L.146, A:L.146 Hydrogen bonds: A:R.22, A:R.22, A:S.97

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chamberlain, P. et al., Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes. Plos One (2014)

Release Date

2014-08-27

Peptides

Serine/threonine-protein kinase N1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase N1

Related Entries With Identical Sequence